Page last updated: 2024-10-19

phosphoenolpyruvate and Placenta Diseases

phosphoenolpyruvate has been researched along with Placenta Diseases in 1 studies

Phosphoenolpyruvate: A monocarboxylic acid anion derived from selective deprotonation of the carboxy group of phosphoenolpyruvic acid. It is a metabolic intermediate in GLYCOLYSIS; GLUCONEOGENESIS; and other pathways.
phosphoenolpyruvate : A monocarboxylic acid anion resuting from selective deprotonation of the carboxy group of phosphoenolpyruvic acid.
phosphoenolpyruvic acid : A monocarboxylic acid that is acrylic acid substituted by a phosphonooxy group at position 2. It is a metabolic intermediate in pathways like glycolysis and gluconeogenesis.

Placenta Diseases: Pathological processes or abnormal functions of the PLACENTA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mameesh, MS1
Metcoff, J1
Costiloe, P1
Crosby, W1

Other Studies

1 other study available for phosphoenolpyruvate and Placenta Diseases

ArticleYear
Kinetic properties of pyruvate kinase in human maternal leukocytes in fetal malnutrition.
    Pediatric research, 1976, Volume: 10, Issue:6

    Topics: Alanine; Allosteric Regulation; Female; Fructosephosphates; Glycolysis; Humans; Kinetics; Leukocytes

1976